Tag: OTCQX
Zolmitriptan Derivatives and Novel Drug Delivery Systems Aim to treat Acute...
Migraine is a genetic predisposition to moderate-to-severe headaches caused due to stress, physiological factors such as lack of sleep, hunger and environmental triggers such...
Curaleaf Holding: Forging the largest acquisition in U.S cannabis landscape
The shares of Curaleaf (OTCQX: CURLF) surged by almost 15% since the news of its acquisition of Cura Partners, the owner of Select brand, in...
Acreage Holdings – “On a High” with news of Acquisition by...
The Canadian cannabis behemoth Canopy Growth Inc (NYSE:CGC), a global leader in diversified cannabis and hemp related products, entered into a definitive agreement with Acreage Holdings,...
Is Autologous Stem Cell Therapy the next frontier of medicine?
Stem Cell Therapy is emerging as the future of therapeutics for numerous diseases and disorders which have hitherto been unaddressed. The growing awareness of...
Scientific Breakthrough seeks to end the suffering of people with Vitiligo
Vitiligo is an autoimmune condition that is characterized by loss of pigmentation, that affected 150, 000 Americans across all age groups according to a...
Timely Diagnosis and Precise Action – The Need of the Hour...
Sepsis is when the body reacts extremely to an infection and can quickly escalate into a life-threatening situation causing multiple organ failures. It affects...
We are looking for talented interns to learn and help investors find valuable companies.